PL2651423T3 - Lactococcus lactis strains for use in improving digestive condition - Google Patents
Lactococcus lactis strains for use in improving digestive conditionInfo
- Publication number
- PL2651423T3 PL2651423T3 PL10813085T PL10813085T PL2651423T3 PL 2651423 T3 PL2651423 T3 PL 2651423T3 PL 10813085 T PL10813085 T PL 10813085T PL 10813085 T PL10813085 T PL 10813085T PL 2651423 T3 PL2651423 T3 PL 2651423T3
- Authority
- PL
- Poland
- Prior art keywords
- lactococcus lactis
- lactis strains
- improving digestive
- digestive condition
- condition
- Prior art date
Links
- 241000194035 Lactococcus lactis Species 0.000 title 1
- 235000014897 Streptococcus lactis Nutrition 0.000 title 1
- 230000001079 digestive effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP10813085.7A EP2651423B1 (en) | 2010-12-17 | 2010-12-17 | Lactococcus lactis strains for use in improving digestive condition |
| PCT/IB2010/055913 WO2012080789A1 (en) | 2010-12-17 | 2010-12-17 | Lactococcus lactis strains for use in improving digestive condition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2651423T3 true PL2651423T3 (en) | 2016-05-31 |
Family
ID=44502202
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL10813085T PL2651423T3 (en) | 2010-12-17 | 2010-12-17 | Lactococcus lactis strains for use in improving digestive condition |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US9408878B2 (en) |
| EP (1) | EP2651423B1 (en) |
| JP (1) | JP5989661B2 (en) |
| CN (1) | CN103370073B (en) |
| BR (1) | BR112013015255A2 (en) |
| ES (1) | ES2557578T3 (en) |
| PL (1) | PL2651423T3 (en) |
| RU (1) | RU2567009C2 (en) |
| WO (1) | WO2012080789A1 (en) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2970986T3 (en) * | 2013-03-08 | 2024-06-03 | Univ California | Polyphosphate-functionalized inorganic nanoparticles as hemostatic compositions and methods of use |
| WO2015023268A1 (en) * | 2013-08-13 | 2015-02-19 | President And Fellows Of Harvard College | Leveraging oxidative stress pathways in lactic acid bacteria to promote gut homeostasis |
| US10383921B2 (en) | 2013-08-13 | 2019-08-20 | President And Fellows Of Harvard College | Leveraging oxidative stress pathways in lactic acid bacteria to promote gut homeostasis |
| ES2929100T3 (en) * | 2014-10-28 | 2022-11-24 | Medlab Ip Pty Ltd | Treatment for depression and depressive disorders |
| CN104382948A (en) * | 2014-11-21 | 2015-03-04 | 江南大学 | Application method of lactococcus lactis in treating intestinal diseases |
| JP6152231B1 (en) * | 2017-01-06 | 2017-06-21 | 株式会社日本バリアフリー | Intestinal flora improving agent |
| EP3656389A4 (en) * | 2017-07-18 | 2021-11-03 | Keio University | ANTIBACTERIAL COMPOSITION AGAINST TH1 CELL INDUCING BACTERIA |
| WO2019211382A1 (en) * | 2018-05-03 | 2019-11-07 | Crigasseni Ag | Probiotic bacterial strains producing antimicrobial proteins and compositions comprising these for use in the treatment of diarrheal and other microbial diseases |
| WO2020157297A1 (en) * | 2019-02-01 | 2020-08-06 | Institut National De Recherche Pour L'agriculture, L'alimentation Et L'environnement | Lactococcus lactis strains for the prevention and/or the treatment of visceral pain |
| EP3957367A4 (en) * | 2019-03-07 | 2023-03-22 | Keio University | ANTIBACTERIAL COMPOSITION AGAINST DRUG RESISTANT BACTERIA OR PRO-INFLAMMATORY BACTERIA |
| JP7469332B2 (en) * | 2019-05-13 | 2024-04-16 | サミ-サビンサ グループ リミテッド | Fructophilic lactic acid producing bacteria |
| TW202106872A (en) * | 2019-07-03 | 2021-02-16 | 國立大學法人弘前大學 | Novel lactic acid bacterium derived from amur cork trees inhabiting Shirakami mountaneous region |
| EP4009797A1 (en) * | 2019-08-09 | 2022-06-15 | Compagnie Gervais Danone | Fermented compositions and processes of preparing the same |
| CN116121110B (en) * | 2022-10-28 | 2024-10-25 | 益加生物科技成都有限公司 | Lactococcus lactis YJ0801 with strong antibacterial and anti-inflammatory effects and application thereof |
| CN117736943B (en) * | 2024-02-20 | 2024-05-24 | 山东中科嘉亿生物工程有限公司 | A composite bacterial agent for improving irritable bowel syndrome and its preparation method and use |
| CN120230688A (en) * | 2025-05-30 | 2025-07-01 | 内蒙古科拓生物有限公司 | Application of Lactococcus lactis subsp. cremoris and its products in improving the effects of enteritis on body weight, intestine and immunity |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2740471B1 (en) * | 1995-10-31 | 1997-12-19 | Gervais Danone Co | LACTIC FERMENTS AND THEIR USE FOR OBTAINING HYPOCHOLESTEROLEMIZING PRODUCTS |
| US20030092163A1 (en) | 2001-07-26 | 2003-05-15 | Collins John Kevin | Probiotic bifidobacterium strains |
| AU2003275532A1 (en) * | 2002-09-25 | 2004-04-19 | Kumamoto Flour Milling Co., Ltd. | Antibacterial substance produced by lactic acid bacterium |
| FR2855182B1 (en) * | 2003-05-19 | 2005-08-05 | Gervais Danone Sa | NOVEL PROCESS AND INOCULUM FOR ACIDIFYING LACTIC FERMENTATION |
| JP4589618B2 (en) * | 2003-11-28 | 2010-12-01 | 独立行政法人農業生物資源研究所 | Lactic acid bacteria and their components inducing immunoregulatory functions |
| EP1743647B1 (en) * | 2004-03-31 | 2016-12-28 | Meiji Co., Ltd. | Antibacterial composition |
| SI2277524T1 (en) | 2005-09-28 | 2016-02-29 | Nordisk Rebalance A/S | Treatment of IBS using both probiotic bacteria and fermented cereal as treatment effectors |
| WO2009066537A1 (en) * | 2007-11-19 | 2009-05-28 | Meiji Dairies Corporation | Immunoregulatory function inducer and food composition |
| EP2072053B1 (en) | 2007-12-21 | 2012-11-07 | Compagnie Gervais Danone | Method for decreasing abdominal girth by administering a bifidobacterium bacteria |
-
2010
- 2010-12-17 PL PL10813085T patent/PL2651423T3/en unknown
- 2010-12-17 JP JP2013543895A patent/JP5989661B2/en active Active
- 2010-12-17 BR BR112013015255A patent/BR112013015255A2/en not_active Application Discontinuation
- 2010-12-17 RU RU2013132931/10A patent/RU2567009C2/en active
- 2010-12-17 US US13/994,376 patent/US9408878B2/en active Active
- 2010-12-17 WO PCT/IB2010/055913 patent/WO2012080789A1/en not_active Ceased
- 2010-12-17 ES ES10813085.7T patent/ES2557578T3/en active Active
- 2010-12-17 CN CN201080070737.0A patent/CN103370073B/en active Active
- 2010-12-17 EP EP10813085.7A patent/EP2651423B1/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP2651423B1 (en) | 2015-09-30 |
| BR112013015255A2 (en) | 2016-09-13 |
| RU2567009C2 (en) | 2015-10-27 |
| EP2651423A1 (en) | 2013-10-23 |
| US20130336944A1 (en) | 2013-12-19 |
| US9408878B2 (en) | 2016-08-09 |
| CN103370073A (en) | 2013-10-23 |
| RU2013132931A (en) | 2015-01-27 |
| CN103370073B (en) | 2017-12-05 |
| ES2557578T3 (en) | 2016-01-27 |
| JP2014501100A (en) | 2014-01-20 |
| JP5989661B2 (en) | 2016-09-07 |
| WO2012080789A1 (en) | 2012-06-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL2651423T3 (en) | Lactococcus lactis strains for use in improving digestive condition | |
| ZA201208977B (en) | Probiotic strains for use in improving the enteric nervous system | |
| PL2498789T3 (en) | Probiotic bifidobacterium strain | |
| GB201016925D0 (en) | Graphene oxide | |
| PT2481299T (en) | Bifidobacterium bifidum strains for application in gastrointestinal diseases | |
| EP2592933A4 (en) | Mif inhibitors and their uses | |
| EP2554568A4 (en) | Polyimide nanocomposite and method for preparing same | |
| EP2583651A4 (en) | Wheelchair and bed | |
| PL2630265T3 (en) | Texturizing lactic acid bacteria strains | |
| EP2646412A4 (en) | Synthetic acid and associated methods | |
| PT2539989T (en) | Drive system and machine | |
| PL2521769T3 (en) | Lactobacilli with anti-oxidant action | |
| ZA201208978B (en) | Probiotic strains for use in improving transepithelial resistance | |
| PT2707477T (en) | Bacterial strains capable of metabolizing oxalates | |
| PL2531039T3 (en) | Use of sialidase in dairy technology | |
| IL222821A0 (en) | Spnk strains | |
| GB201014904D0 (en) | Travel pillow | |
| EP2648572A4 (en) | Mattress arrangement | |
| LT2531076T (en) | Mattress pad | |
| GB2477495A8 (en) | Inflatable cushions | |
| TWM433166U (en) | Pillow | |
| GB201007379D0 (en) | Bacterial secretion | |
| GB201005441D0 (en) | Improvements in wheelchairs | |
| TWM388255U (en) | Pneumatic massage sofa | |
| RS20100436A3 (en) | Autochthonous lactobacillus strains and their use as probiotics |